recombinant humanized 15H8 monocolonal antibody (Aronora)

N/A

Report date: 2025/03/20 10:06:17

Base Information

Drug Namerecombinant humanized 15H8 monocolonal antibody (Aronora)
Drug Alias NameHLS factor XII inhibitor (Aronora)rh15H8 (Aronora)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCoagulation factor XII modulators
TargetsCoagulation factor XII
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAronora Inc
China Registration ClassN/A

Develop Information

Active CompaniesAronora Inc
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A